About us

GeneMedi specializes in creating superior antibody, protein, and vector-based bioproducts, revolutionizing diagnostics and therapeutic solutions.
GeneMedi Vision : Curiosity & Creativity to Improve Human Health

We develop solutions for the therapeutics and diagnostics industry.

Capability

At GeneMedi, innovation, product integrity, and scalable solutions form the cornerstone of our mission to advance the field of diagnostics and therapeutics. Our portfolio of antibodies, proteins, and vector-derived products is built on a foundation of unparalleled expertise in the following areas:

Innovative Antigen Design and Robust Assay Development

Our strategic focus on biomarkers and targets analysis enables the creation of highly specific antigens and the development of robust assays, ensuring our products achieve superior performance in clinical and research settings.

Streamlined Molecular Discovery with Emphasis on Stability

Rapid Protein & Antibody Identification: Our proprietary platforms, TAURUS for accelerated antibody discovery and LIBRA for AI-driven protein evolution, are designed to identify and optimize molecules with optimal stability and functionality.

Rapid Protein & Antibody Identification: Cutting-Edge AAV & GCT Discoveries: The G-NEXT platform is our answer to the industry's need for innovative AAV vectors, offering improved stability, efficiency, and safety for groundbreaking gene therapy approaches.

Scalable Production and Uncompromising Quality

High-Volume Protein & Antibody Manufacturing: Our facilities are equipped to handle large-scale production up to 1000L per batch, ensuring high levels of purity and stability through stringent quality controls.

Advanced Vector Manufacturing Capabilities: With a focus on AAV, lentivirus, and VLP production up to 200L per batch, we employ sophisticated purification techniques to guarantee vector efficacy and integrity.

Comprehensive Solutions for Diverse Application Needs

Diagnostics: Our diagnostic solutions leverage CLIA, LFA, and ELISA platforms for comprehensive assay validation and clinical sample consistency, setting new standards in diagnostic accuracy.

Therapeutics: We specialize in analytical development for ADCs, AAV therapies, and CAR-X technologies, ensuring our therapeutic products are characterized by their specificity, potency, and safety.

GeneMedi (GM) is dedicated to delivering innovative and scalable biotechnological solutions, driving forward the fields of diagnostics and therapeutics with confidence and expertise. Contact with GM to reach your reliable industrial partner.

Partnership

Citation

Publications	Link to the article	Products/Services
H. Zhu, et. al, 'Moderate Uv Exposure Enhances Learning and Memory by Promoting a Novel Glutamate Biosynthetic Pathway in the Brain', Cell, 173 (2018), 1716-27 e17	PMID: 29779945	AAV virus
H. Yang et. al, 'Laterodorsal Tegmentum Interneuron Subtypes Oppositely Regulate Olfactory Cue-Induced Innate Fear', Nat Neurosci, 19 (2016), 283-9.	PMID: 26727549	AAV virus
X. Du, et. al, 'Local Gabaergic Signaling within Sensory Ganglia Controls Peripheral Nociceptive Transmission', J Clin Invest, 127 (2017), 1741-56.	PMID: 28375159	AAV virus
Y. Wang et.al, 'Trpv1 Sumoylation Regulates Nociceptive Signaling in Models of Inflammatory Pain', Nat Commun, 9 (2018), 1529.	PMID: 29670121	AAV virus
Y. Yang et. al, 'Improved Calcium Sensor Gcamp-X Overcomes the Calcium Channel Perturbations Induced by the Calmodulin in Gcamp', Nat Commun, 9 (2018), 1504.	PMID: 29666364	AAV virus
X. Wu et.al, 'Cug-Binding Protein 1 Regulates Hsc Activation and Liver Fibrogenesis', Nat Commun, 7 (2016), 13498.	PMID: 27853137	AAV virus
C. Wang et.al, 'Synaptotagmin-11 Is a Critical Mediator of Parkin-Linked Neurotoxicity and Parkinson's Disease-Like Pathology', Nat Commun, 9 (2018), 81.	PMID: 29311685	AAV virus
D. Feng et.al, 'Pre-Ischemia Melatonin Treatment Alleviated Acute Neuronal Injury after Ischemic Stroke by Inhibiting Endoplasmic Reticulum Stress-Dependent Autophagy Via Perk and Ire1 Signalings', J Pineal Res, 62 (2017).	PMID: 28178380	AAV virus
C. Li et.al. 'Targeting Aldh2 for Therapeutic Interventions in Chronic Pain-Related Myocardial Ischemic Susceptibility', Theranostics, 8 (2018), 1027-41.	PMID: 29463997	AAV virus
L. Tao et.al, 'Crucial Role of Mir-433 in Regulating Cardiac Fibrosis', Theranostics, 6 (2016), 2068-83.	PMID: 27698941	AAV virus
X. Zhang et.al, 'Endoplasmic Reticulum Stress Induced by Tunicamycin and Thapsigargin Protects against Transient Ischemic Brain Injury: Involvement of Park2-Dependent Mitophagy', Autophagy, 10 (2014), 1801-13.	PMID: 25126734	AAV virus
Y. Yuan et.al, 'Bnip3l/Nix-Mediated Mitophagy Protects against Ischemic Brain Injury Independent of Park2', Autophagy, 13 (2017), 1754-66.	PMID: 26727549	AAV virus
L. Li et.al, 'Brown Adipocytes Can Display a Mammary Basal Myoepithelial Cell Phenotype in Vivo', Mol Metab, 6 (2017), 1198-211.	PMID: 29031720	AAV virus
Y. Wei et.al, 'Prevention of Muscle Wasting by Crispr/Cas9-Mediated Disruption of Myostatin in Vivo', Mol Ther, 24 (2016), 1889-91.	PMID: 27916995	AAV virus
N. et.al, 'Cholinergic Grb2-Associated-Binding Protein 1 Regulates Cognitive Function', Cereb Cortex, 28 (2018), 2391-404.	PMID: 28591834	Peptide synthesis

Click the categories below to see citations of other products

Publication AAV	Publication Lentivirus	Publication Adenovirus
Publication Lipogene™	Publication Autophagy	Publication Other Products/Services

Products & Services

Diagnostics Solution

Catagory
Validation

In Vitro Diagnostics

Detail

Veterinary Diagnostics

Detail

Food/Feed & Environmental

Detail

Biologics Solution

Catagory
Validation

Solution for Therapeutic Protein & Antibody & ADC Development

Anti-ADC Payload antibody:anti-MMAE/MMAF, anti-Dxd/Exatecan, anti-DM1/DM4 etc.
In-vivo Grade Antibodies: INN Mab, Bispecific, ADC, Nanobody,Neutralizing Antibody, etc
Hot Target: Protein/VLP/Assay Cellline/Expression vector

Solution for Gene Therapy Development

PURPROX™ AAVEasy Purification Kit
PURPROX™ AAVPure Affinity Resins
TRUEX™ AAV Titration Kits (ELISA)
Anti-AAV Serotypes antibodies
INDKan™ Industry-Used AAV Vector System
GM Multi-Serotype AAV Vector System
GM Promise™ ORF Viral Library

Solution for Cell Therapy Development

SOLIDEX™
SOLIDEX™ -TAGEx CAR-Analytical Tools: Anti-FMC63, Anti-G4S linker, Anti-VHH1 (Naked/PE/APC/FITC)
SOLIDEX™ -CDEx Flow Cytometry Antibodies (Naked/PE/APC/FITC)
SOLIDEX™-ISOExT Immunocytes Cell Isolation Immunomagnetic Beads(IMB)
CAR-X Good-Validated Premade Lenti-CAR Particles